Sentinel surveillance for influenza A viruses in Lahore District Pakistan in flu season 2015-2016.

Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE

Original Publication: London : BioMed Central, [2001-

Influenza A virus* ; Influenza, Human*/epidemiology; Humans ; Infant ; Influenza A Virus, H3N2 Subtype ; Pakistan/epidemiology ; Prospective Studies ; Seasons ; Sentinel Surveillance

Background: Influenza A virus (IAV) remains an important global public health threat with limited epidemiological information available from low-and-middle-income countries. The major objective of this study was to describe the proportions, temporal and spatial distribution, and demographic and clinical characteristics of IAV positive patients with influenza like illness (ILI) and severe acute respiratory illness (SARI) in Lahore, Pakistan.
Methods: Prospective surveillance was established in a sentinel hospital from October 2015 to May 2016. All eligible outpatients and inpatients with ILI or SARI were enrolled in the study. Nasal and/or throat swabs were collected along with clinico-epidemiological data. Samples were tested by real-time RT-PCR (rRT-PCR) to identify IAV and subtype. The descriptive analysis of data was done in R software.
Results: Out of 311 enrolled patients, 284 (91.3%) were ILI and 27 (8.7%) were SARI cases. A distinct peak of ILI and SARI activity was observed in February. Fifty individuals (16%) were positive for IAV with peak positivity observed in December. Of 50 IAV, 15 were seasonal H3N2, 14 were H1N1pdm09 and 21 were unable to be typed. The majority of IAV positive cases (98%) presented with current or history of fever, 88% reported cough and 82% reported sore throat. The most common comorbidities in IAV positive cases were hepatitis C (4%), obesity (4%) and tuberculosis (6%). The highest incidence of patients reporting to the hospital was seen three days post symptoms onset (66/311) with 14 of these (14/66) positive for IAV.
Conclusion: Distinct trends of ILI, SARI and IAV positive cases were observed which can be used to inform public health interventions (vaccinations, hand and respiratory hygiene) at appropriate times among high-risk groups. We suggest sampling from both ILI and SARI patients in routine surveillance as recommended by WHO.
(© 2022. The Author(s).)

Open Forum Infect Dis. 2019 Mar 19;6(3):ofz020. (PMID: 30906797)
Influenza Other Respir Viruses. 2020 May;14(3):257-265. (PMID: 32032469)
PLoS One. 2019 Jul 19;14(7):e0219376. (PMID: 31323025)
PLoS One. 2018 Feb 21;13(2):e0193263. (PMID: 29466459)
PLoS One. 2013 Nov 08;8(11):e79959. (PMID: 24260327)
PLoS One. 2009 Nov 11;4(11):e7776. (PMID: 19936224)
PLoS One. 2012;7(8):e41866. (PMID: 22916112)
Braz J Infect Dis. 2018 Sep - Oct;22(5):377-386. (PMID: 30391275)
Environ Health Perspect. 2011 Apr;119(4):439-45. (PMID: 21097384)
J Clin Microbiol. 2011 Jul;49(7):2614-9. (PMID: 21593260)
Euro Surveill. 2017 Apr 6;22(14):. (PMID: 28422004)
Influenza Other Respir Viruses. 2020 Sep;14(5):530-540. (PMID: 32410402)
Epidemics. 2015 Dec;13:10-16. (PMID: 26097505)
Front Immunol. 2019 May 10;10:1071. (PMID: 31134099)
Arch Intern Med. 2000 Nov 27;160(21):3243-7. (PMID: 11088084)
J Virol. 2014 Jul;88(14):7692-5. (PMID: 24789791)
J Infect Dis. 2012 Dec 15;206 Suppl 1:S87-93. (PMID: 23169978)
Vaccine. 2007 Jun 28;25(27):5086-96. (PMID: 17544181)
Epidemiol Infect. 2015 Oct;143(14):2950-8. (PMID: 25648399)
Int J Mol Sci. 2017 Aug 07;18(8):. (PMID: 28783091)
PLoS One. 2015 Jul 31;10(7):e0133178. (PMID: 26230666)
J Infect Dis. 2014 Jul 15;209 Suppl 3:S93-9. (PMID: 24966196)
PLoS One. 2014 Jun 23;9(6):e98615. (PMID: 24955962)
N Engl J Med. 2010 Nov 18;363(21):2036-44. (PMID: 21083388)
PLoS One. 2012;7(9):e44511. (PMID: 22984519)
J Med Virol. 2020 Apr 21;:. (PMID: 32314812)
Liver Int. 2014 May;34(5):700-6. (PMID: 23981146)
JAMA. 2021 Sep 14;326(10):899-900. (PMID: 34431979)
Lancet Infect Dis. 2005 Nov;5(11):718-25. (PMID: 16253889)
Influenza Other Respir Viruses. 2016 Sep;10(5):367-74. (PMID: 27239956)
PLoS One. 2007 Jun 06;2(6):e491. (PMID: 17551572)
BMC Infect Dis. 2019 Jan 10;19(1):42. (PMID: 30630435)
Influenza Other Respir Viruses. 2014 Jan;8(1):53-65. (PMID: 24209711)
PLoS Med. 2016 Mar 24;13(3):e1001977. (PMID: 27011229)
BMC Infect Dis. 2015 Mar 22;15:143. (PMID: 25885096)
Clin Infect Dis. 2006 Sep 1;43(5):564-8. (PMID: 16886147)
PLoS One. 2020 Mar 4;15(3):e0229601. (PMID: 32130243)
Emerg Infect Dis. 2015 Apr;21(4):673-6. (PMID: 25811830)
PLoS One. 2014 Feb 24;9(2):e89178. (PMID: 24586575)
Bull World Health Organ. 2018 Feb 1;96(2):122-128. (PMID: 29403115)
Prev Vet Med. 2014 Dec 1;117(3-4):610-4. (PMID: 25457514)
J Infect Public Health. 2017 Nov - Dec;10(6):881-883. (PMID: 28185822)
PLoS Med. 2006 Apr;3(4):e89. (PMID: 16509764)
Cent Eur J Public Health. 2016 Sep;24(3):180-187. (PMID: 27755859)
PLoS One. 2016 Dec 9;11(12):e0167866. (PMID: 27936139)
J Prev Med Hyg. 2016;57(1):E19-22. (PMID: 27346935)
BMC Infect Dis. 2020 Feb 18;20(1):148. (PMID: 32070275)
PLoS One. 2009 Dec 29;4(12):e8452. (PMID: 20041114)

Grant# Pak-US/HEC/2015/11, Pakistan; US/Grant#GDL-PakUS-2015-013, USA Pak-US Science and Technology cooperation Program; Grant# Pak-US/HEC/2015/11, Pakistan; US/Grant#GDL-PakUS-2015-013, USA Pak-US Science and Technology cooperation Program; Grant# Pak-US/HEC/2015/11, Pakistan; US/Grant#GDL-PakUS-2015-013, USA Pak-US Science and Technology cooperation Program

Keywords: Active surveillance; Influenza; Influenza like illness (ILI); Pandemic; Seasonal influenza; Severe acute respiratory illness (SARI)

Date Created: 20220107 Date Completed: 20220110 Latest Revision: 20220110

20221213

PMC8734537

10.1186/s12879-021-07021-7

34991508